EndeavorRx
K号: K231337 · 2023-12-13
广告
决定日期2023-12-13
产品代码QFT
咨询委员会OB
请注意，由于您没有提供具体的医疗设备监管文本，我无法进行翻译。请提供具体的文本内容，以便我能够按照您的要求进行翻译。
决定实质等同
器械摘要
EndeavorRx is the device name listed in this FDA 510(k) record. The listed applicant is Akili Interactive Labs, Inc.. It received FDA 510(k) clearance on 2023-12-13 under 510(k) number K231337. The device is classified under product code QFT. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.
常见问题
What is the EndeavorRx?
EndeavorRx is a medical device that received FDA 510(k) clearance on 2023-12-13. The listed applicant is Akili Interactive Labs, Inc.. The 510(k) number is K231337.
When did EndeavorRx receive FDA 510(k) clearance?
EndeavorRx received FDA 510(k) clearance on 2023-12-13, under 510(k) number K231337.
Who is the listed applicant for EndeavorRx?
The FDA 510(k) record lists Akili Interactive Labs, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for EndeavorRx?
The FDA product code for EndeavorRx is QFT.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
列明Akili Interactive Labs, Inc.为申报人的其他记录
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
相关器械（代码：QFT）
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告